The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


A novel approach to treat in-stent restenosis: 6- and 12-month results using the everolimus-eluting bioresorbable vascular scaffold

EuroIntervention 2016;11:1479-1486. DOI: 10.4244/EIJV11I13A287

Department of Cardiology, Luzerner Kantonsspital, Lucerne, Switzerland

Aims: The treatment of in-stent restenosis (ISR) remains challenging. Small case series have described successful utilisation of bioresorbable vascular scaffolds (BVS) (Absorb; Abbott Vas

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Patient preference regarding assessment of clinical follow-up after percutaneous coronary intervention: the PAPAYA study